BDNF promotes mouse follicular development and reverses ovarian aging by promoting cell proliferation
Open Access
- 27 April 2023
- journal article
- research article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 16 (1) , 1-14
Abstract
Background: Brain-derived neurotrophic factor (BDNF) plays an important role in ovarian function including follicle development and oocyte maturation, and embryonic development. However, whether BDNF treatment can reimpose ovarian aging and impaired fertility remains elusive. In this study, we investigated the reproductive outcomes of BDNF treatment and potential mechanisms in aged mice. Method: “Aged” mice (35–37 weeks old, n = 68) were treated with recombinant human BDNF protein (rhBDNF, 1 µg/200 µL) through daily intraperitoneal (IP) injection for 10 days with/without ovulation induction. Reproductive age mice (8–10 weeks old, n = 28) were treated with ANA 12 (a selective BDNF receptor, TrkB antagonist) through daily IP injection for 5 days with/without ovulation induction. Ovarian function was assessed by ovarian weight, number of follicles, and sex hormone productions. Following induction of ovulation, the number of total oocytes or abnormal oocytes, and blastocyst formation were assessed. Reproductive functions of the mice were evaluated, including pregnancy rate, mating duration for conception, implantation sites, litter size, and weight of offspring. Finally, the molecular mechanism of the effects of BDNF on ovarian cell functions in mice were examined by Western blot and immunofluorescence. Results: rhBDNF treatment increased the ovarian weight, number of follicles, number and quality of oocytes including increased blastocysts formation, blood estrogen levels, and pregnancy rate in 35-37-week-old mice. Conversely, BDNF receptor antagonist, ANA 12, treatment decreased the ovarian volume and number of antral follicles and increased the proportion of abnormal oocytes in 8-10-week-old mice. We further demonstrated that BDNF treatment promoted ovarian cell proliferation as well as activation of TrkB and cyclinD1-creb signalling. Conclusion: We demonstrated that ten consecutive days of daily IP injection of rhBDNF rescued ovarian function in aged mice. Our results further indicate that TrkB and cyclin D1-creb signaling may underlie the BDNF function in ovaries. Targeting BDNF-TrkB signaling is a potential novel therapeutic strategy to reverse ovarian aging.Keywords
Funding Information
- National Natural Science Foundation of China (41991314)
- Shanghai Municipal Health Commission (2020CXJQ01: GWV-10.1-XK07)
This publication has 70 references indexed in Scilit:
- Mitochondria-Ros Crosstalk in the Control of Cell Death and AgingJournal of Signal Transduction, 2011
- Neurotrophins Acting Via TRKB Receptors Activate the JAGGED1-NOTCH2 Cell-Cell Communication Pathway to Facilitate Early Ovarian DevelopmentEndocrinology, 2011
- Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in miceJournal of Clinical Investigation, 2011
- Oxidative Damage Increases and Antioxidant Gene Expression Decreases with Aging in the Mouse OvaryBiology of Reproduction, 2010
- Differential expression and regulation by activin of the neurotrophins BDNF and NT4 during human and mouse ovarian developmentDevelopmental Dynamics, 2010
- Transcriptional role of cyclin D1 in development revealed by a genetic–proteomic screenNature, 2010
- Loss of inhibin alpha uncouples oocyte-granulosa cell dynamics and disrupts postnatal folliculogenesisDevelopmental Biology, 2009
- Role of Neurotrophic Factors in Early Ovarian DevelopmentSeminars in Reproductive Medicine, 2009
- Brain derived neurotrophic factor circulating levels in patients undergoing IVFJournal of Assisted Reproduction and Genetics, 2007
- Aging: A Theory Based on Free Radical and Radiation ChemistryJournal of Gerontology, 1956